In this article, the authors test ocellatin peptides against one of the most concerning priority pathogens, Pseudomonas aeruginosa.
Browsing: Basic > Drug Development
Take a look at the top news stories of the week, including the FDA approval of HIV drug Biktarvy and the discovery of a genetic predisposition to congenital Zika syndrome.
In a recent study published in Nature Communications, researchers validated a novel screening approach to identify host-directed compounds that reduce the replication of intracellular pathogens, Julie Kaiser explains.
The end of January saw the London Centre for Neglected Tropical Disease Research’s (LCNTDR; UK) annual anniversary event, this year commemorating the sixth anniversary of the London Declaration on Neglected Tropical Diseases (NTDs). Discover more about the research presented in this report.
Take a look at the top news stories of the week, including a focus on antimicrobial resistance and industry, and new influenza research.
A new benchmark has been launched by the Access to Medicine Foundation comparing pharmaceutical companies in their action to tackle growing antimicrobial resistance
In this article, from Future Medicinal Chemistry, the researchers synthesize a new series of pyrazolo[1,5-c]pyrimidines via hybridization strategies and evaluate these for in vitro activity against leishmaniasis
Researchers have developed a drug delivery system that could allow antiretroviral drugs for HIV to be administered only once a week, potentially making it easier for patients to adhere to drug regimens.
To round up 2017, we asked our Expert panel to choose their top papers from the year. Here, you can discover these articles and the reasons why they were chosen.